# ZEALAND PHARMA US, INC. hires DLA PIPER LLP (US) (Medicare/Medicaid)

**Score:** 30/100

| Field | Value |
|---|---|
| Client | ZEALAND PHARMA US, INC. |
| Client description | Biopharmaceutical company |
| Client state | MA |
| Lobbying firm | DLA PIPER LLP (US) |
| Firm state | DC |
| Issue areas | Medicare/Medicaid |
| Specific matters disclosed | Coverage of anti-obesity medications under Medicare and Medicaid. |
| Registered | 2026-10-07 |

## Why this score


Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/b48d879e-e38e-40a8-9fdb-3a046d77aab2/print/). Last refreshed: 2026-11-04T21:45:03.363Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.